Last updated on May 2018

A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Spondyloarthritis


Brief description of study

The main purpose of this study is to evaluate the safety and efficacy of the study drug known as ixekizumab in biologic disease modifying antirheumatic drug (bDMARD) nave participants with nonradiographic axial spondyloarthritis (nonrad-axSpA).

Clinical Study Identifier: NCT02757352

Contact Investigators or Research Sites near you

Start Over

Eli Lilly and Company

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician
Sasebo, Japan
2.51miles
  Connect »